CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 121 enrolled
Drug / intervention
Revolution™ Peripheral Atherectomy Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02961894
NCT02961894N/ACompleted

Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization

Rex Medical·interventional·Posted Nov 11, 2016·Updated Nov 2, 2020

In Brief

A clinical study evaluating Revolution™ Peripheral Atherectomy System for Peripheral Artery Disease. Completed, enrolled 121 participants across 17 sites.

Detailed Summary

To evaluate the safety and effectiveness of the Revolution™ Peripheral Atherectomy System in the treatment of infrainguinal lower extremity peripheral arterial occlusive disease. This Atherectomy system will be used on eligible patients with stenosis of at least 70% diameter reduction to evaluate the change in stenosis after the procedure (effectiveness) and the presence of any major adverse events (safety) for up to 30 days after the procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsSyntactx

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 11, 2016
Enrollment StartJun 7, 2017
Primary CompletionFeb 28, 2019
Study CompletionSep 20, 2019
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.6 years ago

Interventions

Revolution™ Peripheral Atherectomy Systemdevice

The Rex Medical Revolution™ Peripheral Atherectomy System is a minimally invasive catheter-based atherectomy system used to treat patients who suffer from PAD. This system is designed to treat a broad range of plaque types both above and below the knee and may address many of the limitations associated with existing treatment options.